Business · 02/12/2004Updated: 10/17/2026 · 1 min read
FDA Approves New Dosage Forms for Progesterone and Estradiol Benzoate Animal Drugs
Summary
The FDA has amended its regulations to reflect the approval of new animal drug applications for subcutaneous implants containing progesterone and estradiol benzoate, with warnings against using these products in calves destined for veal production.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →